Prof Weren Fall 12'
Tuesday 6p-8: 40p
Pfizer Case Study
1 . So why has the pharmaceutical drug industry been so successful historically? The pharmaceutical industry has been these kinds of a successful industry for many reasons: • Patent safety is considered to be a motivation for investment, and also makes customer dedication. •Generic brands have been profitable and inexpensive for customers. This simply means that suppliers don't need to offer a particular brand name; all they need include is the active ingredients that brand name suppliers that contain the same function as name brand medications. •Insurance availability for prescribed drugs such as Medicare insurance Part N for the elderly, which spend on the cost of medicine. •The overall flexibility in price mark-ups through the OECD countries. ALL OF US pharmaceutical producers have received in least 60 per cent of product sales profits. •The lack of Gov't involvement with price regulations & Point out funding for drug insurances.
2 . The pharmaceutical sector will become more competitive; boundaries to entrance will not be this kind of a big threat. For example the obvious holder period of time was two decades which restricted competitors to produce, or provide the medicine to get used commercially, and along comes an alternative drug (break-through drug) created by another supplier, with not too many constraints and the same active ingredient the patent holder has which usually cures similar illness which the first medication does. Although patent laws were produced Generic brands have even now become considerably more popular. In Pfizers circumstance I believe experienced they certainly not invested in their particular generic brands the sales would have fallen a long time ago. By 2005 industry for brand name drug fall, 90% coming from all prescribed medications were common. Pfizer was affected by the industry crash in 2007 and the failure of Torcetrapib.
3. Competition within the market will most depend on the market change, the evolution of recent chemicals with fewer side effects and the position of...